Measuring concordance of data sources used for infectious disease research in the USA: a retrospective data analysis
BMJ Open · 2023
DOI: 10.1136/bmjopen-2022-065751 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMJ Open, 2023. Verfasst von Maimuna S Majumder und 2 weiteren Autor:innen. Beteiligte Einrichtung: Computational Health Informatics, Boston Children's Hospital, Boston, Massachusetts, USA maimuna.majumder@childrens.harvard.edu. Hauptthemen laut MEDLINE: Information Sources, COVID-19. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIMHD NIH HHS, AHRQ HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Objectives
As highlighted by the COVID-19 pandemic, researchers are eager to make use of a wide variety of data sources, both government-sponsored and alternative, to characterise the epidemiology of infectious diseases. The objective of this study is to investigate the strengths and limitations of sources currently being used for research.
Design
Retrospective descriptive analysis. Primary and secondary outcome measures Yearly number of national-level and state-level disease-specific case counts and disease clusters for three diseases (measles, mumps and varicella) during a 5-year study period (2013–2017) across four different data sources: Optum (health insurance billing claims data), HealthMap (online news surveillance data), Morbidity and Mortality Weekly Reports (official government reports) and National Notifiable Disease Surveillance System (government case surveillance data).
Results
Our study demonstrated drastic differences in reported infectious disease incidence across data sources. When compared with the other three sources of interest, Optum data showed substantially higher, implausible standardised case counts for all three diseases. Although there was some concordance in identified state-level case counts and disease clusters, all four sources identified variations in state-level reporting.
Conclusions
Researchers should consider data source limitations when attempting to characterise the epidemiology of infectious diseases. Some data sources, such as billing claims data, may be unsuitable for epidemiological research within the infectious disease context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Computational Health Informatics, Boston Children's Hospital, Boston, Massachusetts, USA maimuna.majumder@childrens.harvard.edu.
- Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Health Policy, Stanford University, Stanford, California, USA.
ORCID-Profile: Maimuna S Majumder, Marika Cusick
Förderung
- NIMHD NIH HHS
- AHRQ HHS
- NCATS NIH HHS
- National Institutes of Health
- Agency for Healthcare Research and Quality
Zitieren
APA
Majumder, M. S., Cusick, M., & Rose, S. (2023). Measuring concordance of data sources used for infectious disease research in the USA: a retrospective data analysis. BMJ Open. https://doi.org/10.1136/bmjopen-2022-065751
Vancouver
Majumder MS, Cusick M, Rose S. Measuring concordance of data sources used for infectious disease research in the USA: a retrospective data analysis. BMJ Open. 2023. doi:10.1136/bmjopen-2022-065751
BibTeX
@article{Majumder2023,
author = {Majumder, Maimuna S and Cusick, Marika and Rose, Sherri},
title = {Measuring concordance of data sources used for infectious disease research in the USA: a retrospective data analysis},
journal = {BMJ Open},
year = {2023},
doi = {10.1136/bmjopen-2022-065751}
}
EUVIMED